News

The website offers company’s expanded list of chemical research tools as well as GMP active pharmaceutical ingredients and excipients. The chemical library of unique compounds is now more

The company is also believed to be on track to submit the New Drug Application (NDA) for AG200-15 to the US Food and Drug Administration (FDA) during the

As per the agreement, CCS’s highly flexible service becomes available for EMD Millipore’s well-proven assay cell lines, improving customers’ drug discovery and throughput functional screening capabilities. EMD Millipore

The manufacturing practices are believed to help in longer storage of medicines, The Hindu reported. The news agency quoted Lyka Labs saying to Bombay Stock Exchange that they

The company has raised $2.8m in the current share offering, with $1.3m in shares remaining to be sold, bizjournals.com reported. Heat Biologics is developing HIV vaccine besides other

In the latest financing round, Celator has raised $2.57m of its $5m target through equity, options and securities, medcitynews.com reported. The company’s investors include Quaker BioVentures, Ventures West,

Both the companies will take charge of developing new drug to treat and stopping the progression of dry Age-related Macular Degeneration (AMD), news.cens.com reported. The Phase II and

According to the company, the product featuring transdermal delivery technology reflects the company’s strength and capabilities. Fuse Science CIO and chief marketing officer Aitan Zacharin said until now

Proteonomix entered into a deal to conduct the clinical trial with the University of Miami, under which the University was required to pay expenses associated with the clinical